Irdabisant

CAS : 1005402-19-6

Ref. 3D-BI184163

Informations sur le produit

• Nom: Irdabisant
• Synonymes: 6-[4-[3-[(2R)-2-Methyl-1-pyrrolidinyl]propoxy]phenyl]-3(2H)-pyridazinoneCEP 26401
• Marque: Biosynth
• Description: Irdabisant is a novel small-molecule therapeutic, which functions as a histamine H3 receptor antagonist or inverse agonist. This compound is chemically synthesized and designed to target the central nervous system. The mode of action involves the selective inhibition of presynaptic H3 receptors, which are primarily responsible for modulating the release of histamine and other neurotransmitters such as acetylcholine, norepinephrine, and dopamine. By inhibiting these receptors, Irdabisant enhances neurotransmitter release, facilitating improved synaptic transmission.

Propriétés chimiques

• Masse moléculaire: 313.39 g/mol
• Formule: C₁₈H₂₃N₃O₂
• Degré de pureté: Min. 95%